A Rahman
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery 7
- Oncology top 10%
- Cancer Treatment and Pharmacology 6
-
- Chemotherapy-induced cardiotoxicity and mitigation 5
-
- Advanced biosensing and bioanalysis techniques 6
- RNA Interference and Gene Delivery 5
- Glycosylation and Glycoproteins Research 2
- DNA and Nucleic Acid Chemistry 2
- Pharmaceutical Science top 10%
-
- Virus-based gene therapy research 1
- Co-authors
- Joseph TreatAnatoly DritschiloV J FerransPaul V. WoolleyDeborah ForstErik HermanP. ScheinJae Kyung Roh
- Journals
- JNCI Journal of the National Cancer Institute (3 papers)British Journal of Cancer (2 papers)Journal of Clinical Oncology (1 paper)
- Partner nations
- United StatesPakistanSaudi Arabia
In The Last Decade
A Rahman
18 papers receiving 898 citations
Peers
Comparison fields: 5 of 79
- Biomaterials 344
- Oncology 385
- Cardiology and Cardiovascular Medicine 161
- Molecular Biology 436
- Pharmaceutical Science 35
Countries citing papers authored by A Rahman
This map shows the geographic impact of A Rahman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Rahman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Rahman more than expected).
Fields of papers citing papers by A Rahman
This network shows the impact of papers produced by A Rahman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Rahman. The network helps show where A Rahman may publish in the future.
Co-authorship network
The 25 scholars most cited alongside A Rahman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 0 | |
| 4 | Liposomal-encapsulated chemotherapy: preliminary results of a phase I study of a novel liposomal paclitaxel. | 2001 | 33 |
| 5 | 1999 | 46 | |
| 6 | 1999 | 45 | |
| 7 | 1998 | 85 | |
| 8 | 1997 | 55 | |
| 9 | 1996 | 54 | |
| 10 | 1993 | 72 | |
| 11 | 1992 | 41 | |
| 12 | Liposomal delivery as a new approach to transport antisense oligonucleotides. | 1992 | 20 |
| 13 | 1990 | 99 | |
| 14 | 1990 | 131 | |
| 15 | Membrane alterations by liposomes to enhance clinical efficacy of cytotoxic drugs. | 1990 | 1 |
| 16 | 1989 | 16 | |
| 17 | 1986 | 30 | |
| 18 | 1983 | 7 | |
| 19 | Toxicity evaluation of doxorubicin entrapped in cardiolipin liposomes in mice. Abstr. | 1983 | 3 |
| 20 | Prevention of chronic doxorubicin cardiotoxicity in beagles by liposomal encapsulation. | 1983 | 143 |
About A Rahman
A Rahman is a scholar working on Biomaterials, Oncology and Cardiology and Cardiovascular Medicine, having authored 21 papers that have together received 930 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (7 papers), Cancer Treatment and Pharmacology (6 papers), Advanced biosensing and bioanalysis techniques (6 papers), RNA Interference and Gene Delivery (5 papers), Chemotherapy-induced cardiotoxicity and mitigation (5 papers), Glycosylation and Glycoproteins Research (2 papers), DNA and Nucleic Acid Chemistry (2 papers) and Virus-based gene therapy research (1 paper). The work is most often cited by research in Biomaterials (344 citations), Oncology (385 citations) and Cardiology and Cardiovascular Medicine (161 citations). A Rahman has collaborated with scholars based in United States, Pakistan and Saudi Arabia. Frequent co-authors include Joseph Treat, Anatoly Dritschilo, V J Ferrans, Paul V. Woolley, Deborah Forst, Erik Herman, P. Schein, Jae Kyung Roh, Alain R. Thierry and Prafulla C. Gokhale. Their work appears in journals such as JNCI Journal of the National Cancer Institute, British Journal of Cancer, Journal of Clinical Oncology, Journal of Pharmaceutical Innovation and Biomedical Chromatography.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.